Sort by
Refine Your Search
-
with scientific programming (e.g., MATLAB, LabView) is advantageous Knowledge of scientific instrumentation and electronics is desired Experience with (or willingness to learn) stop-flow spectroscopy and
-
are essential to develop new disease biomarkers and glycan-based therapies. Tasks: you will contribute to the cutting-edge research in the Schumann lab to generate chemical tools that probe and investigate
-
on the remit of the Department here on our homepage. The fixed term is based on the German Academic Fixed-Term Contract Act. Tasks: The assessment of mixtures and their toxicity remains a regulatory and
-
breakage models, e.g. with stochastic tessellations Development and implementation of estimation methods for the model parameters, e.g. with machine learning or statistical methods Lab work and collection
-
exercises, mindfulness-based exercises, pain education, and healthy practice habits. Your primary role will be to develop the physical exercise component of the intervention. The project is a collaboration
-
methods for the contactless detection of plant conditions. The position is being advertised as part of the joint project ‘DHYNAmite - Integrative plant protection through drone-based hyperspectral
-
model complexes. This research is part of a large, funded collaborative project supported by the Swiss National Science Foundation, involving partner researchers based in Germany, Switzerland, and France
-
for a PhD position in Pharmaceutical/Medicinal Chemistry. Funding is supported by the German Research Foundation (DFG) for three years based on a photo-pharmacological project. The position is part time
-
-based electroadsorption devices. Specific requirements: Expertise in advanced synthesis of organic and inorganic materials. The candidate is expected to have expertise or quickly become familiar with
-
on the remit of the Department here on our homepage. The fixed term is based on the German Academic Fixed-Term Contract Act. Tasks: The assessment of mixtures and their toxicity remains a regulatory and